Topical update: new medications for ocular allergy.
Trayner
E M
EM
Englewood Hospital, NJ.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D003233:Conjunctivitis, Allergic / Q000188:drug therapy* / Q000209:etiology; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006801:Humans; D009883:Ophthalmic Solutions; D010072:Oxamic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010880:Piperidines / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D000894:Anti-Inflammatory Agents, Non-Steroidal; D006634:Histamine H1 Antagonists; D009883:Ophthalmic Solutions; D010880:Piperidines; C047340:levocabastine; D010072:Oxamic Acid; C021702:lodoxamide ethyl